STEAP2 promotes hepatocellular carcinoma progression via increased copper levels and stress-activated MAP kinase activity.
Torrez CZ, Easley A, Bouamar H, Zheng G, Gu X, Yang J, Chiu YC, Chen Y, Halff GA, Cigarroa FG, et al. Sci Rep. 2024 Jun 3; 14(1):12753. Epub 2024 Jun 3.